Opinion

Video

Persistence and Discontinuation Rates for Non-Statin Therapies in ASCVD

Author(s):

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP,Kate Cabral, PharmD, BCCP, FACC, FCCP

Clinical insights on how real-world treatment persistence and discontinuation rates compare between the various non-statin therapies and the factors that contribute to these differences.

Related Videos
Hands holding a crochet heart | Image Credit: © StockerThings - stock.adobe.com
Wooden blocks spelling HDL, LDL | Image Credit: © surasak - stock.adobe.com
Anticoagulant attacking blood clot | Image Credit: © BURIN93 - stock.adobe.com
Depiction of man aging | Image Credit: © Top AI images - stock.adobe.com
Map with pins | Image Credit: © Tryfonov - stock.adobe.com
Heart with stethoscope | Image Credit: © DARIKA - stock.adobe.com
Image Credit: © abricotine - stock.adobe.com
This series features 5 KOLs.
This series features 5 KOLs.
This series features 5 KOLs.
Related Content
Blood cells | Image Credit: © Formoney - stock.adobe.com
November 19th 2024

Abelacimab Reduces Bleeding in AF Patients on Antiplatelet Therapy

Alexandra Gerlach, Associate Editor
AHA 2024: Email Reminders Improve Flu Shot Rates, Particularly Among Heart Attack Survivors
November 18th 2024

AHA 2024: Email Reminders Improve Flu Shot Rates, Particularly Among Heart Attack Survivors

Aislinn Antrim, MA, Assistant Managing Editor
AHA 2024: Integrating Ambulatory Care Pharmacists in Value-Based Primary Care Improves Cardiometabolic Disease Management
November 17th 2024

AHA 2024: Integrating Ambulatory Care Pharmacists in Value-Based Primary Care Improves Cardiometabolic Disease Management

Aislinn Antrim, MA, Assistant Managing Editor
AHA 2024: Providing Feedback for Pharmacists Improved Care for Veterans With Heart Failure
November 16th 2024

AHA 2024: Providing Feedback for Pharmacists Improved Care for Veterans With Heart Failure

Aislinn Antrim, MA, Assistant Managing Editor
AHA 2024: Tirzepatide Lowers Risk of Worsening Heart Failure, CVD Death in Adults With Obesity
Published: November 16th 2024 | Updated: November 16th 2024

AHA 2024: Tirzepatide Lowers Risk of Worsening Heart Failure, CVD Death in Adults With Obesity

Aislinn Antrim, MA, Assistant Managing Editor
AHA 2024: AI Tool Could Provide Fast, No-Contact Blood Pressure and Diabetes Screenings
November 15th 2024

AHA 2024: AI Tool Could Provide Fast, No-Contact Blood Pressure and Diabetes Screenings

Aislinn Antrim, MA, Assistant Managing Editor